This case was reported by a consumer (patient's son) and described the
occurrence of stroke in a 51-year-old female patient who received Belimumab
(Benlysta) for lupus. A physician or other health care professional has not
verified this report.
The patient's past medical history included non-hodgkin's lymphoma.
Concurrent medical conditions included diabetes and lupus. Concurrent
medications included No concurrent medication. 
On January 2014 the patient started Belimumab (unknown), unknown dosing. On
February 2014, the patient ministrokes. At an unknown time after starting
Belimumab the patient experienced stroke, progressive multifocal
leukoencephalopathy and jc virus. The patient was hospitalised. At the time
of reporting, the events were fatal.
The patient died on (b) (6)  from stroke. It is unknown whether an
autopsy was performed.
Print Time: 24-MAY-2016 07:56 AM If a field is blank, there is no data for that field Page 57 of 570
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
Reporter is the son of the patient. Reporter said that he called to give
information about the stroke that killed his mother. His mother started
Benlysta the first week of January 2014. Specific dates not provided. Patient
then had several mini-strokes that led her to a nursing home in February
2014. Specific dates not available. Reporter said that she was in and out of
the hospital several times and the company could contact her physician to get
all the details. Reporter said that his mother also got the PML from the JC
virus. Patient died on (b) (6)  at 1:27 a.m. Reporter was told at the
Hospital, that Benlysta caused his mother's death.